AI boosts pharma R&D ROI by shortening discovery and trials, improving success rates, enabling recurring software revenue, and shifting sponsors to flexible outsourced services.Dublin, Nov. 13, 2026 ...
A new sampling algorithm, the open-closed mod-minimizer, reduces the space required for genomic indexes by up to 18 percent ...
Opinion
Jensen Huang's Exit Was an Export-Control Hit, Not a Scandal, Says AI Researcher Wissner-Gross
Jensen Huang's resignation as NVIDIA CEO is best read as enforcement of the U.S. silicon curtain, not a personal collapse — and polymarket ...
Nuclear stability requires mutual vulnerability. Artificial general intelligence could upset asymmetric deterrence equilibria, especially vis-à-vis Pyongyang.
Companies including Anthropic, Meta and OpenAI are knowingly building technology that poses catastrophic risks to humanity, ...
Cloud-native GPU infrastructure turns fixed capex into flexible costs, while AI-led validation and optimization reduce screening time, synthesis cycles and early-stage attrition.Dublin, Nov. 13, 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results